Brian Haab, Ph.D., appointed to editorial board of the Journal Molecular & Cellular Proteomics
Grand Rapids, Mich. (June 26, 2009) – Brian Haab, Ph.D., senior scientific investigator in the Laboratory of Cancer Immunodiagnostics at Van Andel Research Institute (VARI), has been named to the Editorial Board of the journal Molecular & Cellular Proteomics.
“This is one of the top journals in proteomics,” said Dr. Haab. “It is an honor to be recognized in this field by being invited to join their editorial board.”
The term “proteome” refers to the entire set of protein found in a genome, cell, tissue or organism at a given time under a particular set of environmental conditions. Proteome research is often focused on the impact of genetic mutation on an organism’s proteins.
Molecular & Cellular Proteomics covers the full gamut of research in proteomics and has played a major role in setting standards in proteomics. The journal is published by the American Society for Biochemistry and Molecular Biology, which also publishes the Journal of Biological Chemistry, the largest single biochemistry journal in the world. Editorial board terms are for five years but can be renewed at the end of the term.
Dr. Haab was previously elected to a three-year term on the Board of Directors of the US Human Proteome Organization, and to a three-year term on the editorial advisory board of the Journal of Proteome Research. Dr. Haab obtained his Ph.D. in chemistry from the University of California at Berkeley in 1998. He then served as a postdoctoral fellow in the laboratory of Patrick Brown in the Department of Biochemistry at Stanford University. Dr. Haab joined VARI as a special program investigator in May 2000 and became a scientific investigator in 2004. He was promoted to the rank of senior scientific investigator in 2007.
# # #
About Van Andel Institute
Established by Jay and Betty Van Andel in 1996, Van Andel Institute (VAI) is an independent research and educational organization based in Grand Rapids, Mich., dedicated to preserving, enhancing and expanding the frontiers of medical science, and to achieving excellence in education by probing fundamental issues of education and the learning process. VARI, the research arm of VAI, is dedicated to probing the genetic, cellular and molecular origins of cancer, Parkinson and other diseases and working to translate those findings into effective therapies. This is accomplished through the work of over 200 researchers in 18 on-site laboratories, in laboratories in Singapore and Nanjing, and in collaborative partnerships that span the globe.
